Viewing Study NCT05628103


Ignite Creation Date: 2025-12-24 @ 7:45 PM
Ignite Modification Date: 2026-01-01 @ 5:55 PM
Study NCT ID: NCT05628103
Status: COMPLETED
Last Update Posted: 2025-12-11
First Post: 2022-11-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-12-19
Start Date Type: ACTUAL
Primary Completion Date: 2024-04-01
Primary Completion Date Type: ACTUAL
Completion Date: 2024-04-01
Completion Date Type: ACTUAL
First Submit Date: 2022-11-16
First Submit QC Date: None
Study First Post Date: 2022-11-28
Study First Post Date Type: ACTUAL
Results First Submit Date: 2025-10-30
Results First Submit QC Date: None
Results First Post Date: 2025-11-12
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2024-06-26
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2025-11-24
Last Update Post Date: 2025-12-11
Last Update Post Date Type: ESTIMATED